moderna
Moderna soars on analyst upgrade
Moderna's stock surges on positive analyst outlook, reflecting the potential of its innovative mRNA-based vaccines and therapies.
Moderna CFO Quits After Only One Day on the Job -- And Cashes Out With His Entire First-Year Salary
The biotech company announced that Jorge Gomez was leaving his position, effective immediately.
Moderna Shares Spike After Company Says Its Covid Booster Increases Antibody Levels Against Omicron
The company also has plans to continue the development of a booster specifically targeting Omicron, which is expected to enter clinical trials in early 2022.
Moderna Says Its Vaccine Is 96% Effective in Teens
The pharmaceutical company made the announcement while also revealing its financial results for the first quarter.
Pfizer Vaccine to Be Approved for 12- to 15-Year-Olds
The FDA will authorize the use of the Pfizer Covid-19 vaccine in teens, as the U.S. moves forward to vaccinate other age groups.
Moderna Will Distribute 34 Million Doses of Covid-19 Vaccine to Struggling Countries
The vaccine distribution is part of a global initiative that grants equal access to Covid-19 vaccines in countries that have been severely impacted.